These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1816189)

  • 1. Penetration of ceftazidime into bronchial secretions in critically ill patients.
    Langer M; Cantoni P; Bellosta C; Boccazzi A
    J Antimicrob Chemother; 1991 Dec; 28(6):925-32. PubMed ID: 1816189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of aztreonam and penetration into the bronchial secretions of critically ill patients.
    Boccazzi A; Langer M; Mandelli M; Ranzi AM; Urso R
    J Antimicrob Chemother; 1989 Mar; 23(3):401-7. PubMed ID: 2732121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ceftazidime absorption into bronchial secretions in mucoviscidosis patients].
    Berthelot G; Lenoir G; Grenier B; Tournier G; Sardet A; Steru D; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):430-4. PubMed ID: 3897974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The penetration of macrolides into bronchial secretions.
    Pierre J; Bergogne-Berezin E; Kafe H; Dournovo P
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():217-20. PubMed ID: 4055550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients.
    Stein GE; Smith CL; Scharmen A; Kidd JM; Cooper C; Kuti J; Mitra S; Nicolau DP; Havlichek DH
    Surg Infect (Larchmt); 2019 Jan; 20(1):55-61. PubMed ID: 30351195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of cefotaxime into bronchial secretions.
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Rev Infect Dis; 1982; 4 Suppl():S392-5. PubMed ID: 6294788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of ciprofloxacin into bronchial secretions.
    Bergogne-Bérézin E; Berthelot G; Even P; Stern M; Reynaud P
    Eur J Clin Microbiol; 1986 Apr; 5(2):197-200. PubMed ID: 2941280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penetration of netilmicin into respiratory secretions].
    Bergogne-Berezin E; Berthelot G; Even P; Safran D
    Presse Med; 1983 Feb; 12(5):287-92. PubMed ID: 6220386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffusion of piperacillin into bronchial secretions].
    Bergogne-Bérézin E; Berthelot G; Kafe H
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):653-6. PubMed ID: 3534762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability.
    Bressolle F; de la Coussaye JE; Ayoub R; Fabre D; Gomeni R; Saissi G; Eledjam JJ; Galtier M
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1404-11. PubMed ID: 1510435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum and bronchial concentrations of netilmicin during its continuous intratracheal administration].
    Aguilera D; Coupry A; Holzapfel L; Karlin P; Carrère-Debat D; Giudicelli DP; Gontier D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):657-62. PubMed ID: 3534763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions.
    Bergogne-Berezin E; Morel C; Benard Y; Berthelot G; Kafe H
    Scand J Infect Dis Suppl; 1978; (14):267-72. PubMed ID: 279981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of ampicillin into human bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Kafe H; Morel C
    Infection; 1979; 7 Suppl 5():S463-4. PubMed ID: 511358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent bolus dosing of ceftazidime in critically ill patients.
    Young RJ; Lipman J; Gin T; Gomersall CD; Joynt GM; Oh TE
    J Antimicrob Chemother; 1997 Aug; 40(2):269-73. PubMed ID: 9301994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.
    Saux P; Martin C; Mallet MN; Papazian L; Bruguerolle B; De Micco P; Gouin F
    Antimicrob Agents Chemother; 1994 Apr; 38(4):901-4. PubMed ID: 8031070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of ceftazidime into intracranial abscess.
    Green HT; O'Donoghue MA; Shaw MD; Dowling C
    J Antimicrob Chemother; 1989 Sep; 24(3):431-6. PubMed ID: 2681122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of ciprofloxacin in bronchial secretions after intravenous administration.
    Berré J; Thys JP; Husson M; Gangji D; Klastersky J
    J Antimicrob Chemother; 1988 Oct; 22(4):499-504. PubMed ID: 3204076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.